A Certified Reference Material
Features
  • This product is qualified as a Certified Reference Material (CRM) that has been manufactured and tested to meet ISO/IEC 17025 and ISO 17034 international standards
  • This CRM has been characterized by metrologically valid procedures and may be used as a quantitative analytical reference standard
  • Certificate of analysis provides the certified property values and the associated uncertainties, including a statement of metrological traceability for the certified values
  • Possession of a DEA Controlled Substance registration is not necessary nor is a DEA 222 form required to purchase this product
  • Bulk material is available for qualified institutions; please contact our sales department for pricing
Related Products
Active Metabolite(s)
3802010α-hydroxy-exo-THC3802210α-hydroxy-Δ8-THC3635411-hydroxy-9(S)-Hexahydrocannabinol3635311-hydroxy-9(R)-Hexahydrocannabinol4412811-hydroxy-9(R)-Hexahydrocannabinol (exempt preparation)4412911-hydroxy-9(S)-Hexahydrocannabinol (exempt preparation)399729α,10α-epoxy Hexahydrocannabinol446929α,10α-epoxy Hexahydrocannabinol (exempt preparation)446109α,10α-epoxy Hexahydrocannabinol (exempt preparation)
Alternative(s)
42138Δ9-THC (Alt. Batch CRM)ISO60157Δ9-THC (CRM)45655Δ9-THC (CRM)
Analytical Standard(s)
9003740(±)-Δ9-THC12068Δ9-THC
Isomer(s)
38947(+)-cis-Cannabidiol9003416(+)-Cannabidiol35329(+)-Δ8-THC33453(+)-Δ9-THC34628(+)-Δ9-THC (exempt preparation)27074(±)-cis-Δ9-THC42464(±)-cis-Δ9-THC (CRM)26252(±)-Cannabichromene41376(±)-Cannabichromene (Alt. Batch CRM)9002438(±)-Cannabicyclol42627(±)-Cannabicyclol (Alt. Batch CRM)22036(±)-Cannabicyclol (CRM)9003741(±)-Cannabidiol9003740(±)-Δ9-THC34629(±)-Δ9-THC (exempt preparation)33011(6aR,9R)-Δ10-THC (CRM)41814(6aR,9R)-Δ10-THC (Alt. Batch CRM)42625(6aR,9S)-Δ10-THC (Alt. Batch CRM)33012(6aR,9S)-Δ10-THC (CRM)41297(9,10a)-anti-Δ6a,7-THC (exempt preparation)37046(9,10a)-anti-Δ6a,7-THC37047(9,10a)-syn-Δ6a,7-THC41298(9,10a)-syn-Δ6a,7-THC (exempt preparation)426299(R)-Δ6a,10a-THC (Alt. Batch CRM)330139(R)-Δ6a,10a-THC (CRM)340769(R)-Δ7-THC391879(R)-Δ7-THC (CRM)330149(S)-Δ6a,10a-THC (CRM)421419(S)-Δ6a,10a-THC (Alt. Batch CRM)393179(S)-Δ7-THC (CRM)10004259Abnormal Cannabidiol37475Cannabicitran41377Cannabicitran (Alt. Batch CRM)21295Cannabicitran (CRM)90080Cannabidiol41217Cannabidiol (Alt. Batch CRM)ISO60156Cannabidiol (CRM)ISO60183Cannabinol (CRM)41216exo-THC (Alt. Batch CRM)36898exo-THC (CRM)33863Δ4(8)-iso-THC39955Δ4(8)-iso-THC (CRM)33862Δ4-iso-THC33864Δ8-iso-THC39000Δ8-iso-THC (CRM)14042Δ8-THC41193Δ8-THC (Alt. Batch CRM)
Labeled Version(s)
41210Δ9-THC-d3 (CRM)19332Δ9-THC-d3 (CRM)34918Δ9-THC-d9 (CRM)45656Δ9-THC-d9 (CRM)
Metabolite(s)
21667(±)-11-hydroxy-Δ9-THC (CRM)41185(±)-11-hydroxy-Δ9-THC (CRM)20754(±)-11-nor-9-carboxy-Δ9-THC (CRM)41286(±)-11-nor-9-carboxy-Δ9-THC (CRM)14239(−)-11-hydroxy-Δ9-THC40600(−)-11-nor-9-carboxy-Δ9-THC (CRM)397948β-hydroxy-Δ9-THC (exempt preparation)376358β-hydroxy-Δ9-THC446079β,10β-epoxy Hexahydrocannabinol (exempt preparation)446959β,10β-epoxy Hexahydrocannabinol (exempt preparation)420239β,10β-epoxy Hexahydrocannabinol39623Δ9-THC Glucuronide
Reference Material(s)
9003771Δ9-THC (solution)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Δ9-THC (CRM)

A 100 µg/ml solution in methanol

Item No. 43003

Exempt Product (US)
Safety Data Sheet (SDS) (PDF)
Synonyms
Synonyms
  • Dronabinol
  • NSC 134454
  • Δ9-Tetrahydrocannabinol
Technical Information
CAS Number
1972-08-3
Molecular Formula
C21H30O2
Formula Weight
314.5
Formulation
A 100 µg/ml solution in methanol
SMILES
CC1=C[C@]2([H])[C@@](C(C)(C)OC3=C2C(O)=CC(CCCCC)=C3)([H])CC1
InChi Code
InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1
InChi Key
CYQFCXCEBYINGO-IAGOWNOFSA-N
Origin
Synthetic
Regulatory Information
DEA Exempt Notification
This product is a DEA exempt preparation of a scheduled compound - does not require DEA Controlled Substance registration or DEA 222 form. For alternate sizes please contact sales.
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    100 µg

    $28

    Add
    Cayman Chemical
    Multi-Analyte • Method-Suited • Ready-to-Use

    Want to adjust components or formulation? Cayman provides fast turnaround of custom phytocannabinoid CRM mixtures from our ISO 17034 labs.

    INQUIRE
    Product Description

    Δ9-THC (CRM) (Item No. 43003) is a certified reference material categorized as a cannabinoid.1,2 Δ9-THC is psychoactive and has diverse effects on perception, cognition, and pain sensitivity.3 Δ9-THC (CRM) (Item No. 43003) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

    For more information, please see Cayman's Δ9-THC, Δ10-THC, and Δ6a,10a-THC metabolism monograph.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Huffman, J.W., Padgett, L.W., Isherwood, M.L., et al. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorg. Med. Chem. Lett. 16(20), 5432-5435 (2006).

    2. Pertwee, R.G. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6(8), 635-664 (1999).

    3. Grotenhermen, F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 42(4), 327-360 (2003).